EFFORTLESS Trial Of Boston Scientific’s S-ICD Headlines HRS 2016

Results from 985 patients in EFFORTLESS, the largest post-market registry of Boston Scientific’s S-ICD (subcutaneous ICD), support the technology as an option for a broad population of ICD candidates, according to Lucas V. A. Boersma, an electrophysiologist at St. Antonius Hospital in The Netherlands. He presented data from the registry on May 6 at the Heart Rhythm Society Scientific Sessions in San Francisco.